Observational studyJournal of the American Heart Association2018

Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study.

Eun Ha Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.